India, May 12 -- Shares of an Ahmedabad-based pharmaceutical manufacturer locked into a 20% upper circuit on Tuesday after the company reported a sharp jump in both quarterly and full-year earnings for FY26, drawing renewed attention from retail investors tracking smallcap pharma names.

With a market cap of 1,304 Crore, the shares of Sakar Healthcare Ltd. are trading at a price of 586.95 i.e. 10.82 percent up from its previous closing price of 529.6. In Tuesday trading session it hit an upper circuit of 20% at 635.5 i.e. 20% above its previous closing price. It currently trades at P/E of46.72.

Strong Revenue Momentum Across the Year Sakar Healthcare Limited reported consolidated revenue from operations of 251.74 crore for FY26, up from ...